Aging of the immune system: Focus on inflammation and vaccination

European Journal of Immunology

Volumn 46, Issue 10, 2016, Pages 2286-2301

  Pinti, Marcello ^a   Appay, Victor ^b   Campisi, Judith ^c   Frasca, Daniela ^d   Fülöp, Tamas ^e   Sauce, Delphine ^b   Larbi, Anis ^f   Weinberger, Birgit ^g   Cossarizza, Andrea ^h  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b SORBONNE UNIVERSITÉ   (France)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

^f AGENCY FOR SCIENCE   (Singapore)

^g UNIVERSITY OF INNSBRUCK   (Austria)

^h UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Aging; B lymphocytes; Longevity; NK cells; Signaling; T lymphocytes; Vaccine

Indexed keywords

AGING; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL MATURATION; HUMAN; IMMUNE AGING; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LONGEVITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VACCINATION;

EID: 84990847690     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201546178     Document Type: Review

References (180)

1. Olshansky, S. J., Perry, D., Miller, R. A. and Butler, R. N., Pursuing the longevity dividend: scientific goals for an aging world. Ann. N.Y. Acad. Sci. 2007. 1114: 11–13.
2. The Silver Book. Chronic disease and medical innovation in an aging nation. Published by the Alliance for Aging Research, Updated May, 2011 (http://www.silverbook.org).
3. López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. and Kroemer, G., The hallmarks of aging. Cell 2013. 153:1194–1217.
4. Cevenini, E., Monti, D. and Franceschi, C., Inflamm-ageing. Curr. Opin. Clin. Nutr. Metab. Care 2013. 18: 14–20.
5. Finch, C. E., Morgan, T. E., Longo, V. D. and de Magalhaes, J. P., Cell resilience in species lifespans: a link to inflammation? Aging Cell 2010. 9:519–526.
6. Fagiolo, U., Cossarizza, A., Scala, E., Fanales-Belasio, E., Ortolani, C., Cozzi, E., Monti, D. et al., Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol. 1993. 23: 2375–2378.
7. Puzianowska-Kuźnicka M., Owczarz M., Wieczorowska-Tobis, K., Nadrowski, P., Chudek, J., Slusarczyk, P., Skalska, A. et al., Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study. Immun Ageing. 2016. 3: 13–21.
8. Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z. et al., Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006. 12: 1365–71.
9. Biagi, E., Candela, M., Fairweather-Tait, S., Franceschi, C. and Brigidi, P., Ageing of the human metaorganism: the microbial counterpart. Age 2012. 34: 247–267.
10. Heintz, C. and Mair, W., You are what you host: microbiome modulation of the aging process. Cell 2014. 156: 408–411.
11. Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A. et al., Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol. 2006. 72: 1027–33.
12. Woodmansey E. J., McMurdo, M. E., Macfarlane, G. T. and Macfarlane, S., Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 2004. 70: 6113–6122
13. Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkïla, J. et al., Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010. 5: e10667.
14. Campisi, J. and d'Adda di Fagagna, F., Cellular senescence: when bad things happen to good cells. Nature Rev. Molec. Cell Biol. 2007. 8:729–740.
15. Campisi, J., Senescent cells, tumor suppression and organismal aging: good citizens, bad neighbors. Cell 2005. 120: 513–522.
16. Coppé, J. P., Patil, C. K., Rodier, F., Sun, Y., Munoz, D., Goldstein, J., Nelson, P. S. et al., Senescence-associated secretory phenotypes reveal cell non-automous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008. 6: 2853–2868.
17. Mantovani, A., Chemokines in neoplastic progression. Semin. Cancer Biol. 2004. 14: 147–148.
18. Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C. and Lowe, S. W., Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007. 445: 656–660.
19. Coppé, J. P., Desprez, P. Y., Krtolica, A. and Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 2010. 5: 99–118.
20. Demaria, M., Ohtani, B., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R. M. et al., An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 2014. 31:722–733.
21. Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R. et al., Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 2013. 155:1119–1130.
22. Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., Saltness, R. et al., Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature 2016. 530: 184–189.
23. Rodier, F., Coppé, J. P., Patil, C. K., Hoeijmakers, W. A., Munoz, D. P., Raza, S. R., Freund, A. et al., Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 2009. 11: 973–979.
24. Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K. et al., Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 2016. 23:303–314.
25. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K. et al., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999. 257: 79–83.
26. Ohashi, K., Parker, J. L., Ouchi, N., Higuchi, A., Vita, J. A., Gokce, N., Pedersen, A. A. et al., Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem. 2010. 285: 6153–6160.
27. La Cava, A. and Matarese, G., The weight of leptin in immunity. Nat Rev Immunol. 2004. 4: 371–379.
28. Sarraf, P., Frederich, R. C., Turner, E. M., Ma, G., Jaskowiak, N. T., Rivet, D. J., 3rd, Flier, J. S. et al., Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med. 1997. 185: 171–175.
29. Lumeng, C. N., Liu, J., Geletka, L., Delaney, C., Delproposto, J., Desai, A., Oatmen, K. et al., Aging is associated with an increase in T cells and inflammatory macrophages in visceral adipose tissue. J Immunol. 2011. 187: 6208–6216.
30. Sewter, C. P., Digby, J. E., Blows, F., Prins, J. and O'Rahilly S., Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J Endocrinol. 1999. 163: 33–38.
31. Park, H. S., Park, J. Y. and Yu, R., Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005. 69: 29–35.
32. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S. et al., Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997. 82: 4196–4200.
33. Simpson, R. J., Lowder, T. W., Spielmann, G., Bigley, A. B., LaVoy, E. C., Kunz, H., Exercise and the aging immune system. Ageing Res Rev. 2012. 11: 404–420.
34. Tchkonia, T., Morbeck, D. E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S. et al., Fat tissue, aging, and cellular senescence. Aging Cell. 2010. 9: 667–684.
35. Cossarizza, A., Ortolani, C., Paganelli, R., Barbieri, D., Monti, D., Sansoni, P., Fagiolo, U. et al., CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to healthy centenarians: implications for T cell memory. Mech Ageing Develop. 1996. 86: 173–195.
36. Pinti, M., Cevenini, E., Nasi, M., De Biasi, S., Salvioli, S., Monti, D., Benatti, S. et al., Circulating mitochondrial DNA increases with age and is a familiar trait: implications for "inflamm-aging". Eur. J. Immunol. 2014. 44: 1552–1562.
37. Butcher, S. K., Chahal, H., Nayak, L., Sinclair, A., Henriquez, N. V., Sapey, E., O'Mahony, D. et al., Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J. Leukocyte Biol. 2001. 70: 881–886.
38. Brubaker, A. L., Rendon, J. L., Ramirez, L., Choudhry, M. A. and Kovacs, E. J., Reduced neutrophil chemotaxis and infiltration contributes to delayed resolution of cutaneous wound infection with advanced age. J. Immunol. 2013. 190: 1746–1757.
39. Sapey, E., Greenwood, H., Walton, G., Mann, E., Love, A., Aaronson, N., Insall, R. H. et al., Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence. Blood 2014. 123: 239–248.
40. Nomellini, V., Brubaker, A. L., Mahbub, S., Palmer, J. L., Gomez, C. R. and Kovacs, E. J., Dysregulation of neutrophil CXCR2 and pulmonary endothelial ICAM-1 promotes age-related pulmonary inflammation. Aging Dis. 2012. 3: 234–47.
41. Emanuelli, G., Lanzio, M., Anfossi, T., Romano, S., Anfossi, G. and Calcamuggi, G., Influence of age on polymorphonuclear leukocytes in vitro: phagocytic activity in healthy human subjects. Gerontology 1986. 32: 308–316.
42. Alonso-Fernandez, P., Puerto, M., Mate, I., Ribera, J. M. and de la Fuente, M., Neutrophils of centenarians show function levels similar to those of young adults. J. Am. Geriatr. Soc. 2008. 56: 2244–2251.
43. Tseng, C. W., Kyme, P. A., Arruda, A., Ramanujan, V. K., Tawackoli, W. and Liu, G. Y., Innate immune dysfunctions in aged mice facilitate the systemic dissemination of methicillin-resistant S. aureus. PLoS One 2012. 7: e41454.
44. Metcalf, T. U., Cubas, R. A., Ghneim, K., Cartwright, M. J., Grevenynghe, J. V., Richner, J. M., Olagnier, D. P. et al., Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors. Aging Cell 2015. 14: 421–432.
45. Ziegler-Heitbrock, L., Blood monocytes and their subsets: established features and open questions. Front. Immunol. 2015. 6: 423.
46. Hearps, A. C., Martin, G. E., Angelovich, T. A., Cheng, W. J., Maisa, A., Landay, A. L., Jaworowski, A. et al., Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell 2012. 11: 867–875.
47. Mclachlan, J. A., Serkin, C. D., Morrey, K. M. and Bakouche, O., Antitumoral properties of aged human monocytes. J.Immunol. 1995. 154: 832–843.
48. van Duin, D., Mohanty, S., Thomas, V., Ginter, S., Montgomery, R. R., Fikrig, E., Allore, H. G. et al., Age-associated defect in human TLR-1/2 function. J. Immunol. 2007. 178: 970–975.
49. Qian, F., Wang, X. M., Zhang, L., Chen, S., Piecychna, M., Allore, H., Bockenstedt, L. et al., Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell 2012. 11: 104–110.
50. Mizel, S. B. and Bates, J. T., Flagellin as an adjuvant: cellular mechanisms and potential. J. Immunol. 2010 185: 5677–5682.
51. Weinberger, B., Joos, C., Reed, S. G., Coler, R. and Grubeck-Loebenstein, B., The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age. Biogerontology 2016. 17: 177–187.
52. Panda, A., Qian, F., Mohanty, S., van Duin, D., Newman, F. K., Zhang, L., Chen, S. et al., Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010. 184: 2518–2527.
53. Jing, Y., Shaheen, E., Drake, R. R., Chen, N., Gravenstein, S. and Deng, Y., Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol 2009. 70: 777–784.
54. Perez-Cabezas, B., Naranjo-Gomez, M., Fernandez, M. A., Grifols, J. R., Pujol-Borrell, R. and Borras, F. E., Reduced numbers of plasmacytoid dendritic cells in aged blood donors. Exp Gerontol 2007. 42: 1033–1038.
55. Della Bella, S., Bierti, L., Presicce, P., Arienti, R., Valenti, M., Saresella, M., Vergani, C. et al., Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol 2007. 122: 220–228.
56. Bhushan, M., Cumberbatch, M., Dearman, R. J., Andrew, S. M., Kimber, I. and Griffiths, C. E. M., Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Brit.J. Dermatol. 2002. 146: 32–40.
57. Zavala, W. D. and Cavicchia, J. C., Deterioration of the Langerhans cell network of the human gingival epithelium with aging. Arch. Oral Biol. 2006. 51: 1150–1155.
58. Laube, S., Skin infections and ageing. Ageing Res. Rev. 2004. 3: 69–89.
59. Agrawal A., Agrawal, S., Cao, J. N., Su, H. F., Osann, K. and Gupta, S., Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J. Immunol. 2007. 178: 6912–6922.
60. Janssen, N., Derhovanessian, E., Demuth, I., Arnaout, F., Steinhagen-Thiessen, E. and Pawelec, G., Responses of dendritic cells to TLR-4 stimulation are maintained in the elderly and resist the effects of CMV infection seen in the young. J Gerontol A Biol Sci Med Sci 2016. 71: 1117–1123.
61. do Nascimento, M. P., Pinke, K. H., Penitenti, M., Ikoma, M. R. and Lara, V. S., Aging does not affect the ability of human monocyte-derived dendritic cells to phagocytose Candida albicans. Aging Clin Exp Res 2015. 27: 785–789.
62. Sridharan, A., Esposo, M., Kaushal, K., Tay, J., Osann, K., Agrawal, S., Gupta, S. et al., Age-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity. Age 2011. 33: 363–376.
63. Hart, P. H., Grimbaldeston, M. A., Hosszu, E. K., Swift, G. J., Noonan, F. P. and Finlay-Jones, J. J., Age-related changes in dermal mast cell prevalence in BALB/c mice: functional importance and correlation with dermal mast cell expression of Kit. Immunology 1999. 98: 352–356.
64. Nguyen, M., Pace, A. J. and Koller, B. H., Age-induced reprogramming of mast cell degranulation. J Immunol 2005. 175: 5701–5707.
65. Atsuta, R., Akiyama, K., Shirasawa, T., Okumura, K., Fukuchi, Y. and Ra, C., Atopic asthma is dominant in elderly onset asthmatics: possibility for an alteration of mast cell function by aging through Fc receptor expression. Int Arch Allergy Immunol 1999. 120 Suppl 1: 76–81.
66. Mathur, S. K., Schwantes, E. A., Jarjour, N. N. and Busse, W. W., Age-related changes in eosinophil function in human subjects. Chest 2008. 133: 412–419.
67. Ferrucci, L., Harris T. B., Guralnik J. M., Tracy R. P., Corti M. C., Cohen H. J., Penninx B. et al., Serum IL-6 level and the development of disability in older persons. J. Am. Geriatr. Soc. 1999 47:639–646.
68. Cohen, H. J., Harris, T. and Pieper, C. F., Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am. J. Med. 2003 114: 180–187.
69. Gruver, A. L., Hudson, L. L. and Sempowski, G. D., Immunosenescence of ageing. J Pathol. 2007. 211: 144–156.
70. Pinti, M., Nasi, M., Lugli, E., Gibellini, L., Bertoncelli, L., Roat, E., De Biasi, S. et al., T cell homeostasis in centenarians: from the thymus to the periphery. Curr Pharm Des. 2010. 16:597–603.
71. Shanley, D. P., Aw, D., Manley, N. R. and Palmer D. B., An evolutionary perspective on the mechanisms of immunosenescence. Trends Immunol. 2009. 30: 374–381
72. Nasi, M., Troiano, L., Lugli, E., Pinti, M., Ferraresi, R., Monterastelli, E., Mussi, C. et al., Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: implications for the neolymphogenesis at the extreme limit of human life. Aging Cell 2006. 5: 167–175.
73. Lugli, E., Pinti, M., Nasi, M., Troiano, L., Ferarresi, R., Mussi, C., Salvioli, G. et al., Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data. Cytometry (part A) 2007. 71A: 334–344.
74. Thome, J. J., Yudanin, N., Ohmura, Y., Kubota, M., Grinshpun, B., Sathaliyawala, T., Kato, T. et al., Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell 2014. 159: 814–828.
75. Sauce, D., Larsen, M., Fastenackels, S., Duperrier, A., Keller, M., Grubeck-Loebenstein, B., Ferrand, C. et al., Evidence of premature immune aging in patients thymectomized during early childhood. J Clin Invest 2009. 119: 3070–3078.
76. Zlamy, M., Almanzar, G., Parson, W., Schmidt, C., Leierer, J., Weinberger, B., Jeller, V. et al., Efforts of the human immune system to maintain the peripheral CD8+ T cell compartment after childhood thymectomy. Immun Ageing 2016. 13: 3.
77. Kohler, S. and Thiel, A., Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood 2009. 113: 769–774.
78. Sauce, D., Larsen, M., Fastenackels, S., Roux, A., Gorochov, G., Katlama, C., Sidi, D. et al., Lymphopenia-driven homeostatic regulation of naive T cells in elderly and thymectomized young adults. J. Immunol 2012. 189: 5541–5548.
79. Britanova, O. V., Putintseva, E. V., Shugay, M., Merzlyak, E. M., Turchaninova, M. A., Staroverov, D. B., Bolotin, D. A. et al., Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling. J. Immunol 2014. 192: 2689–2698.
80. Qi, Q., Liu, Y., Cheng, Y., Glanville, J., Zhang, D., Lee, J. Y., Olshen, R. A. et al., Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci U S A. 2014. 111: 13139–13144.
81. Li, G., Yu, M., Lee, W. W., Tsang, M., Krishnan, E., Weyand, C. M. and Goronzy, J. J., Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med 2012. 18: 1518–1524.
82. Briceno, O., Lissina, A., Wanke, K., Afonso, G., von Braun, A., Ragon, K., Miquel, T. et al., Reduced naive CD8(+) T-cell priming efficacy in elderly adults. Aging Cell 2016. 15: 14–21.
83. Bignon, A., Regent, A., Klipfel, L., Desnoyer, A., de la Grange, P., Martinez, V., Lortholary, O. et al., DUSP4-mediated accelerated T-cell senescence in idiopathic CD4 lymphopenia. Blood 2015. 125: 2507–2518.
84. Richner, J. M., Gmyrek G. B., Govero, J., Tu, Y., van der Windt, G. J., Metcalf, T. U., Haddad, E. K. et al., Age-dependent cell trafficking defects in draining lymph nodes impair adaptive immunity and control of West Nile virus infection. PLoS Pathog. 2016. 11: e1005027.
85. Schulz, A. R., Malzer, J. N., Domingo, C., Jurchott, K., Grutzkau, A., Babel, N., Nienen, M. et al., Low thymic activity and dendritic cell numbers are associated with the immune response to primary viral infection in elderly humans. J. Immunol 2015. 195: 4699–4711.
86. Papagno, L., Spina, C. A., Marchant, A., Salio, M., Rufer, N., Little, S., Dong, T. et al., Immune activation and CD8(+) T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2004. 2: E20.
87. Brenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P. et al., Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003. 101: 2711–2720.
88. Gil, A., Yassai, M. B., Naumov, Y. N. and Selin, L. K., Narrowing of human influenza A virus-specific T cell receptor alpha and beta repertoires with increasing age. J. Virol. 2015. 89: 4102–4116.
89. Griffiths, S. J., Riddell, N. E., Masters, J., Libri, V., Henson, S. M., Wertheimer, A., Wallace, D. et al., Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA. J. Immunol. 2013. 190: 5363–5372.
90. Lanna, A., Henson, S. M., Escors, D. and Akbar, A. N., The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat. Immunol. 2014. 15: 965–972.
91. Henson, S. M., Lanna, A., Riddell, N. E., Franzese, O., Macaulay, R., Griffiths, S. J., Puleston, D. J. et al., p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8(+) T cells. J. Clin. Invest. 2014. 124: 4004–4016.
92. Henson, S. M., Macaulay, R., Riddell, N. E., Nunn, C. J. and Akbar, A. N., Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8(+) T-cell proliferation by distinct pathways. Eur. J. Immunol. 2015. 45: 1441–1451.
93. Puleston, D. J., Zhang, H., Powell, T. J., Lipina, E., Sims, S., Panse, I., Watson, A. S. et al., Autophagy is a critical regulator of memory CD8(+) T cell formation. Elife 2014. 3: e03706.
94. Roux, A., Mourin, G., Larsen, M., Fastenackels, S., Urrutia, A., Gorochov, G., Autran, B. et al., Differential impact of age and cytomegalovirus infection on the gammadelta T cell compartment. J. Immunol. 2013. 191: 1300–1306.
95. Wistuba-Hamprecht, K., Frasca, D., Blomberg, B., Pawelec, G. and Derhovanessian, E., Age-associated alterations in gammadelta T-cells are present predominantly in individuals infected with cytomegalovirus. Immun. Ageing 2013. 10: 26.
96. Cooper, M. A., Fehniger, T. A., Fuchs, A., Colonna, M. and Caligiuri, M. A., NK cell and DC interactions. Trends Immunol. 2004. 25: 47–52.
97. Bjorkstrom, N. K., Ljunggren, H. G. and Sandberg, J. K., CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol. 2010. 31: 401–406.
98. Wang, J. W., Geiger, H. and Rudolph, K. L., Immunoaging induced by hematopoietic stem cell aging. Curr. Opin. Immunol. 2011. 23: 532–536.
99. Le Garff-Tavernier, M., Beziat, V., Decocq, J., Siguret, V., Gandjbakhch, F., Pautas, E., Debre, P. et al., Human NK cells display major phenotypic and functional changes over the lifespan. Aging Cell 2010. 9: 527–535.
100. Gayoso, I., Sanchez-Correa, B., Campos, C., Alonso, C., Pera, A., Casado, J. G., Morgado, S. et al., Immunosenescence of human natural killer cells. J. Inn. Immunity 2011. 3: 337–343.
101. Mariani, E., Meneghetti, A., Neri, S., Ravaglia, G., Forti, P., Cattini, L. and Facchini, A., Chemokine production by natural killer cells from nonagenarians. Eur. J Immunol. 2002. 32: 1524–1529.
102. Solana, R., Tarazona, R., Gayoso, I., Lesur, O., Dupuis, G. and Fulop, T., Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Sem Immunol 2012. 24: 331–341.
103. Sanchez-Correa, B., Gayoso, I., Bergua, J. M., Casado, J. G., Morgado, S., Solana, R. and Tarazona, R., Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients. Immunol. Cell Biol. 2012. 90: 109–115.
104. Lutz, C. T., Karapetyan, A., Al-Attar, A., Shelton, B. J., Holt, K. J., Tucker, J. H. and Presnell, S. R., Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults. J. Immunol. 2011. 186: 4590–4598.
105. Bayard, C., Lepetitcorps, H., Roux, A., Larsen, M., Fastenackels, S., Salle, V., Vieillard, V. et al., Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans. Eur. J. Immunol. 2016. 46: 1168–1179.
106. White, M. J., Nielsen, C. M., McGregor, R. H., Riley, E. M. and Goodier, M. R., Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens. Immunology 2014. 142: 140–150.
107. Bjorkstrom, N. K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Ivarsson, M. A., Bjorklund, A. T. et al., Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010. 116: 3853–3864.
108. Zhang, Y., Wallace, D. L., de Lara, C. M., Ghattas, H., Asquith, B., Worth, A., Griffin, G. E. et al., In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 2007. 121: 258–265.
109. Lopez-Verges, S., Milush, J. M., Schwartz, B. S., Pando, M. J., Jarjoura, J., York, V. A., Houchins, J. P. et al., Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci USA 2011. 108: 14725–14732.
110. Guma, M., Angulo, A., Vilches, C., Gomez-Lozano, N., Malats, N. and Lopez-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004. 104: 3664–3671.
111. Beziat, V., Liu, L. L., Malmberg, J. A., Ivarsson, M. A., Sohlberg, E., Bjorklund, A. T., Retiere, C. et al., NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013. 121: 2678–2688.
112. Waldhauer, I. and Steinle, A., NK cells and cancer immunosurveillance. Oncogene 2008. 27: 5932–5943.
113. Ademokun, A., Wu, Y. C. and Dunn-Walters, D., The ageing B cell population: composition and function. Biogerontology 2010. 11: 125–137.
114. Frasca, D., Diaz, A., Romero, M., Phillips, M., Mendez, N. V., Landin, A. M. and Blomberg, B. B., Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine. Int Immunol 2012. 24: 175–182.
115. Frasca, D., Landin, A. M., Lechner, S. C., Ryan, J. G., Schwartz, R., Riley, R. L. and Blomberg, B. B., Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 2008. 180: 5283–5290.
116. Shi, Y., Yamazaki, T., Okubo, Y., Uehara, Y., Sugane, K. and Agematsu, K., Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol 2005. 175: 3262–3267.
117. Fecteau, J. F., Cote, G. and Neron, S., A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J. Immunol. 2006. 177: 3728–3736.
118. Colonna-Romano, G., Bulati, M., Aquino, A., Pellicano, M., Vitello, S., Lio, D., Candore, G. et al., A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people. Mech. Ageing Dev. 2009. 130: 681–690.
119. Pritz, T., Lair, J., Ban, M., Keller, M., Weinberger, B., Krismer, M. and Grubeck-Loebenstein, B., Plasma cell numbers decrease in bone marrow of old patients. Eur. J. Immunol. 2015. 45: 738–746.
120. Frasca, D. and Blomberg, B. B., Aging, cytomegalovirus (CMV) and influenza vaccine responses. Hum. Vaccin. Immunother. 2015. 12: 682–690.
121. Frasca, D., Diaz, A., Romero, M., Landin, A. M. and Blomberg, B. B., High TNF-alpha levels in resting B cells negatively correlate with their response. Exp. Gerontol. 2014. 54: 116–122.
122. Frasca, D., Diaz, A., Romero, M., Landin, A. M. and Blomberg, B. B., Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine 2015. 33: 1433–1439.
123. Frasca, D., Diaz, A., Romero, M., Mendez, N. V., Landin, A. M. and Blomberg, B. B., Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011–2012 influenza vaccine season. Immun. Ageing 2013. 10: 14.
124. Khurana, S., Frasca, D., Blomberg, B. and Golding, H., AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans. PLoS Path. 2012. 8: e1002920.
125. Frasca, D., Diaz, A., Romero, M., Landin, A. M., Phillips, M., Lechner, S. C., Ryan, J. G. et al., Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 2010. 28: 8077–8084.
126. Derhovanessian, E., Theeten, H., Hahnel, K., Van Damme, P., Cools, N. and Pawelec, G., Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 2013. 31: 685–690.
127. McElhaney, J. E., Zhou, X., Talbot, H. K., Soethout, E., Bleackley, R. C., Granville, D. J. and Pawelec, G., The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 2012. 30: 2060–2067.
128. Tabibian-Keissar, H., Hazanov, L., Schiby, G., Rosenthal, N., Rakovsky, A., Michaeli, M., Shahaf, G. L. et al., Aging affects B-cell antigen receptor repertoire diversity in primary and secondary lymphoid tissues. Eur J Immunol. 2016. 46:480–492.
129. Gibson, K. L., Wu, Y. C., Barnett, Y., Duggan, O., Vaughan, R., Kondeatis, E., Nilsson, B. O. et al., B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009. 8: 18–25.
130. Ademokun, A., Wu, Y. C., Martin, V., Mitra, R., Sack, U., Baxendale, H., Kipling, D. et al., Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell 2011. 10: 922–930.
131. Jiang, N., He, J., Weinstein, J. A., Penland, L., Sasaki, S., He, X. S., Dekker, C. L. et al., Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 2013. 5: 171ra119.
132. Fülöp, T., Le Page, A., Fortin, C., Witkowski, J. M., Dupuis, G. and Larbi, A., Cellular signaling in the aging immune system. Curr. Opin. Immunol. 2014. 29: 105–111.
133. Montgomery, R. R. and Shaw, A. C., Paradoxical changes in innate immunity in aging: recent progress and new directions. J. Leukoc. Biol. 2015; 98: 937–943.
134. Fortin, C. F., Larbi, A., Lesur, O., Douziech, N. and Fulop, T. Jr., Impairment of SHP-1 down-regulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to their age-related, altered functions. J. Leukoc. Biol. 2006. 79: 1061–1072.
135. Aspinall, R., Lapenna, A., Lynch, C. and Lang, P. O., Cellular signalling pathways in immune aging and regeneration. Biochem Soc Trans. 2014. 42: 651–656.
136. Goronzy, J. J., Li, G., Yu, M. and Weyand, C. M., Signaling pathways in aged T cells - A reflection of T cell differentiation, cell senescence and host environment. Semin. Immunol. 2012. 24: 365–372.
137. Ponnappan, U., Trebilcock, G. U. and Zheng, M. Z., Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NFkappaB activation in T lymphocytes during aging: evidence for altered IkappaB-alpha phosphorylation and degradation. Exp Gerontol 1999, 34:95–107.
138. LePage, A., Fortin, C., Garneau, H., Allard, N., Tsvetkova, K., Larbi, A., Dupuis, G. et al., Modulation of signaling in lymphocytes from elderly donors. Inhibition of SRC homology 2 domain-containing phosphatase-1 (SHP-1) leads to recovery of T cell. Cell Commun. Signal. 2014; 12:2 (doi: 10.1186/1478-811X-12-2).
139. Larbi, A., Dupuis, G., Khalil, A., Douziech, N., Fortin, C. and Fulop, T. Jr., Differential role of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes with aging. Cell Signal. 2006. 18: 1017–1030.
140. Larbi, A., Kempf, J. and Pawelec G., Oxidative stress modulation and T cell activation. Exp. Gerontol. 2007. 42:852–858.
141. Lenton, K. J., Therriault, H., Cantin, A. M., Fülöp, T., Payette, H. and Wagner, J. R., Direct correlation of glutathione and ascorbate and their dependence on age and season in human lymphocytes. Am. J. Clin. Nutr. 2000. 71: 1194–2000.
142. Griffiths, H. R., Dunston, C. R., Bennett, S. J., Grant, M. M., Phillips, D. C. and Kitas, G. D., Free radicals and redox signalling in T-cells during chronic inflammation and ageing. Biochem. Soc. Trans. 2011. 39:1273–1278.
143. Larbi, A. and Fülöp, T., From "truly naïve" to "exhausted senescent" T cells: when markers predict functionality. Cytometry A. 2014. 85:25–35.
144. Di Mitri, D., Azevedo, R. I., Henson, S. M., Libri, V., Riddell, N. E., Macaulay, R., Kipling, D. et al., Reversible senescence in human CD4+CD45RA+CD27- memory T cells. J. Immunol. 2011. 187:2093–2100.
145. Mannick, J. B., Del Giudice, G., Lattanzi, M., Valiante, N. M., Praestgaard, J., Huang, B., Lonetto, M. A. et al., mTOR inhibition improves immune function in the elderly. Sci. Transl. Med. 2014. 6: 268ra179 (doi: 10.1126/scitranslmed.3009892).
146. Chisolm, D. A. and Weinmann, A. S., TCR-signaling events in cellular metabolism and specialization. Front. Immunol. 2015. 6: 292.
147. Gavazzi, G. and Krause, K. H., Ageing and infection. Lancet Infect. Dis. 2002. 2: 659–666.
148. van Duin, D., Allore, H. G., Mohanty, S., Ginter, S., Newman, F. K., Belshe, R. B., Medzhitov, R. et al., Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J Infect Dis. 2007. 195: 1590–1597.
149. Haynes, L. and Eaton, S. M., The effect of age on the cognate function of CD4+ T cells. Immunol Rev. 2005. 205: 220–228.
150. Goodwin, K., Viboud, C. and Simonsen, L., Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006. 24: 1159–1169.
151. Rockwood, K., Song, X., MacKnight, C., Bergman, H., Hogan, D. B., McDowell, I. and Mitnitski, A., A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005. 173: 489–495.
152. Strandberg, T. E. and Pitkälä, K. H., Frailty in elderly people. Lancet. 2007. 369: 1328–1329
153. Leng, S. X., Cappola, A. R., Andersen, R. E., Blackman, M. R., Koenig, K., Blair, M. and Walston, J. D., Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res. 2004. 16: 153–157.
154. Yao, X., Hamilton, R. G., Weng, N. P., Xue, Q. L., Bream, J. H., Li, H., Tian, J. et al., Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccine 2011. 29: 5015–5021.
155. Nakaya, H. I., Hagan, T., Duraisingham, S. S., Lee, E. K., Kwissa, M., Rouphael, N., Frasca, D. et al., Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures. Immunity 2015. 43: 1186–1198
156. Park, H. L., Shim, S. H., Leem E. Y., Cho, W., Park, S., Jeon, H. J., Ahn et al., Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine. Hum Vaccin Immunother. 2014. 10: 1181–1186.
157. Frasca, D., Ferracci, F., Diaz, A., Romero, M., Lechner, S. and Blomberg, B. B., Obesity decreases B cell responses in young and elderly individuals. Obesity (Silver Spring). 2016. 24: 615–625.
158. Frasca D. and Blomberg, B. B., Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology 2016. 17: 7–19.
159. Zhou, X. and McElhaney, J. E., Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine 2011. 29: 2169–2177.
160. Holland, D., Booy, R., De Looze, F., Eizenberg, P., McDonald, J., Karrasch, J., McKeirnan, M. et al., Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J. Infect. Dis. 2008. 198: 650–658.
161. Falsey, A. R., Treanor, J. J., Tornieporth, N., Capellan, J. and Gorse, G. J., Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J. Infect. Dis. 2009. 200: 172–180.
162. Ott, G., Barchfeld, G. L. and van Nest, G., Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59. Vaccine 1995. 13: 1557–1562.
163. Ansaldi, F., Zancolli, M., Durando, P., Montomoli, E., Sticchi, L., Del Giudice, G. and Icardi, G., Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates. Vaccine 2010. 28: 4123–4129.
164. Osterholm, M. T., Kelley, N. S., Sommer, A. and Belongia, E. A., Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 2012. 12: 36–44.
165. Beyer, W. E., McElhaney, J., Smith, D. J., Monto, A. S., Nguyen-Van-Tam, J. S. and Osterhaus, A. D., Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine 2013. 31: 6030–6033.
166. Wiersma, L. C., Rimmelzwaan, G. F. and de Vries, R. D., Developing universal influenza vaccines: hitting the nail, not just on the head. Vaccines (Basel) 2015. 3: 239–262.
167. Melegaro, A. and Edmunds, W. J., The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. Eur. J. Epidemiol. 2004. 19: 353–363.
168. Bonten, M. J., Huijts, S. M., Bolkenbaas, M., Webber, C., Patterson, S., Gault, S., van Werkhoven C. H. et al., Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N. Engl. J. Med. 2015. 372: 1114–1125.
169. van Werkhoven, C. H., Huijts, S. M., Bolkenbaas, M., Grobbee, D. E. and Bonten, M. J., The impact of age on the efficacy of 13-valent pneumococcal conjugate vaccine in elderly. Clin. Infect. Dis. 2015. 61: 1835–1838.
170. Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D. et al., A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 2005. 352: 2271–2284.
171. Lal, H., Cunningham, A. L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S. J., Levin M. J. et al., Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N. Engl. J. Med. 2015. 372: 2087–2096.
172. Chlibek, R., Bayas, J. M., Collins, H., de la Pinta, M. L., Ledent, E., Mols, J. F. and Heineman, T. C., Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age. J Infect Dis. 2013. 208: 1953–1961.
173. Leroux-Roels, I., Leroux-Roels, G., Clement, F., Vandepapelière, P., Vassilev, V., Ledent, E. and Heineman, T. C., A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults. J Infect Dis. 2012. 206: 1280–1290
174. Didierlaurent, A. M., Collignon, C., Bourguignon, P., Wouters, S., Fierens, K., Fochesato, M., Dendouga, N. et al., Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells. J Immunol. 2014. 193: 1920–1930
175. Weinberger, B., Schirmer, M., Matteucci, G. R., Siebert, U., Fuchs, D. and Grubeck-Loebenstein, B., Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons. PLoS One 2013. 8: e82967.
176. Ridda, I., Yin, J. K., King, C., Raina, M. C. and McIntyre, P., The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly. Vaccine 2012. 30: 6745–6752.
177. Kaml, M., Weiskirchner, I., Keller, M., Luft, T., Hoster, E., Hasford, J., Young, L. et al., Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. Vaccine 2006. 24: 6808–6811.
178. Fleming, D. M., Taylor, R. J., Lustig, R. L., Schuck-Paim, C., Haguinet, F., Webb, D. J., Logie, J. et al., Modelling estimates of the burden of respiratory syncytial virus infection in adults and the elderly in the United Kingdom. BMC Infect. Dis. 2015. 15: 443 (doi: 10.1186/s12879-015-1218-z.).
179. Shaw, C. A., Ciarlet, M., Cooper, B. W., Dionigi, L., Keith, P., O'Brien, K. B., Rafie-Kolpin, M. et al., The path to an RSV vaccine. Curr. Opin. Virol. 2013. 3: 332–342.
180. Cross, A. S, Chen, W. H. and Levine, M. M., A case for immunization against nosocomial infections. J. Leukoc. Biol. 2008. 83: 483–488.